The results showed WWP2 expression in newly diagnosed ALL patients (0.1405 ± 0.1609) was higher than that in CR ALL patients (0.0588 ± 0.1029) and normal control people (0.0099 ± 0.0092). Here, WWP2 is linked to acute lymphoblastic leukemia.